Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 9, 2023
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
[ Thu, Feb 09th 2023
] - WOPRAI
Robert Burns Maintained (ATRA) at Strong Buy with Decreased Target to $675 on, Feb 9th, 2023
Robert Burns of HC Wainwright & Co., Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Buy with Decreased Target from $725 to $675 on, Feb 9th, 2023.
Robert has made no other calls on ATRA in the last 4 months.
There are 2 other peers that have a rating on ATRA. Out of the 2 peers that are also analyzing ATRA, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Salim Syed of "Mizuho" Reiterated at Strong Buy and Held Target at $775 on, Tuesday, February 7th, 2023
- Tony Butler of "EF Hutton" Initiated at Strong Buy and Held Target at $625 on, Thursday, January 5th, 2023
